Indefinite Delivery Contract 36E79720D0035
Award Date
7/30/20
Last Date to Order
7/29/25
Federal Agency
National Acquisition Center
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026. The contract was competitively...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of...
The Indefinite Delivery Contract (IDC) SPE2D222D0147 was awarded by the Defense Logistics Agency (DLA) to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC has a total ceiling value of $10,967,220.00 and a period of performance running through September 13, 2027. Under this contract, Mylan will provide the DLA, Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service with a variety of...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
The federal contract IDV award to Mylan Pharmaceuticals Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Veterans Affairs (VA) National Acquisition Center. The contract, valued at up to $9,549,893.15 over its 5-year period of performance, enables Mylan to supply clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This contract is an extension of Mylan's ongoing role as a prime vendor of specialty...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. to provide pharmaceutical products and medical supplies to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The $6,509,967.70 contract, effective from September 15, 2021 through September 14, 2025, was issued without a set-aside designation. The contract aims to ensure an uninterrupted...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a $1.388 million single-award Indefinite Delivery Contract (IDC) to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, for the supply of Atropine Sulfate/Diphenoxylate Hydrochloride tablets. The contract has a base period of one year from May 27, 2023 to May 26, 2024, with four one-year option periods, for a total potential performance period of 5 years. This IDC allows the VA, Department of Defense, Bureau...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, valued at $267,666.40, is for the supply of Thioridazine HCl tablets in various dosages to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The period of performance is one year from August 19, 2021, with four one-year...
The National Acquisition Center, a civilian agency of the U.S. federal government, has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $761,850 contract is for the supply of lacosamide injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period with four one-year option periods. This IDC was competitively awarded without any...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract issued by the U.S. Department of Veterans Affairs Veterans Integrated Service Network 12 (VHA VISN 12) to Mylan Pharmaceuticals Inc. The contract, valued at up to $364,546,690.00, provides a comprehensive range of drugs and hematology-related products to VA hospitals and clinics over a 5-year period ending December 31, 2027. As a prime contractor, Mylan Pharmaceuticals will deliver critical medications such as...